Recommended resources and works cited:

Click here to view a list of recommended resources as well as citations from Dr. Merritt’s 9/21 presentation.

Articles discussed during Dr. Merritt’s presentation:

Taylor HA, Dowdy DW, Searle AR, Stennett AL, Dukhanin V, Zwerling AA, Merritt MW. Disadvantage and the Experience of Treatment for Multidrug-Resistant Tuberculosis (MDR-TB). SSM Qual Res Health. 2022 Dec;2:100042. doi: 10.1016/j.ssmqr.2022.100042. Epub 2022 Jan 28. PMID: 35252955; PMCID: PMC8896740.

Dowdy DW, Zwerling AA, Stennett A, Searle A, Dukhanin V, Taylor HA, Merritt MW. Measuring Stigma to Assess the Social Justice Implications of Health-Related Policy Decisions: Application to Novel Treatment Regimens for Multidrug-Resistant Tuberculosis. MDM Policy Pract. 2020 Apr 26;5(1):2381468320915239. doi: 10.1177/2381468320915239. PMID: 32440569; PMCID: PMC7227142.

Please join us for the weekly Tuberculosis Research Advancement Center (TRAC) Seminar Series from 12:00 – 1:00 PM ET in CRB-2, 1M.13 or via Zoom: https://jhjhm.zoom.us/j/92237457953 | Add to Calendar

Maria W. Merritt, PhD
Core Faculty, Berman Institute of Bioethics
Associate Professor, Department of International Health, Bloomberg School of Public Health
Johns Hopkins University

My doctoral education was in philosophy, with a post-doctoral fellowship in bioethics. I’m interested in issues of public health ethics in international health. My methods combine philosophical inquiry and (in collaboration with social scientists) qualitative research to understand and address ethical issues as informed by the perspectives of people experiencing them. My current research agenda focuses on ethical aspects of the search for climate solutions.

The September TRAC Seminar Series on “Tuberculosis: Historical, Social, and Ethical Considerations” is presented by the Administrative Core.